فليسينوكسان (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "فليسينوكسان" in Arabic language version.

refsWebsite

Global rank Arabic rank

9doi.org

2^nd place

5^th place

9nih.gov

4^th place

6^th place

7semanticscholar.org

11^th place

86^th place

3archive.org

6^th place

3^rd place

archive.org

Hadrava V، Blier P، Dennis T، Ortemann C، de Montigny C (أكتوبر 1995). "Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study". Neuropharmacology. ج. 34 ع. 10: 1311–26. DOI:10.1016/0028-3908(95)00098-Q. PMID:8570029. S2CID:27967032.
van Hest A، van Drimmelen M، Olivier B (1992). "Flesinoxan shows antidepressant activity in a DRL 72-s screen". Psychopharmacology. ج. 107 ع. 4: 474–9. DOI:10.1007/BF02245258. PMID:1351303. S2CID:6258207.
Rodgers RJ، Cole JC، Davies A (أغسطس 1994). "Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan". Pharmacology, Biochemistry, and Behavior. ج. 48 ع. 4: 959–63. DOI:10.1016/0091-3057(94)90205-4. PMID:7972301. S2CID:39446719.

doi.org

Schoeffter P، Hoyer D (نوفمبر 1988). "Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus". British Journal of Pharmacology. ج. 95 ع. 3: 975–85. DOI:10.1111/j.1476-5381.1988.tb11728.x. PMC:1854240. PMID:3207999.
Pitchot W، Wauthy J، Legros JJ، Ansseau M (مارس 2004). "Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study". European Neuropsychopharmacology. ج. 14 ع. 2: 151–5. DOI:10.1016/S0924-977X(03)00108-1. PMID:15013031. S2CID:19082134.
Hadrava V، Blier P، Dennis T، Ortemann C، de Montigny C (أكتوبر 1995). "Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study". Neuropharmacology. ج. 34 ع. 10: 1311–26. DOI:10.1016/0028-3908(95)00098-Q. PMID:8570029. S2CID:27967032.
Wouters W، Tulp MT، Bevan P (مايو 1988). "Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors". European Journal of Pharmacology. ج. 149 ع. 3: 213–23. DOI:10.1016/0014-2999(88)90651-6. PMID:2842163.
van Hest A، van Drimmelen M، Olivier B (1992). "Flesinoxan shows antidepressant activity in a DRL 72-s screen". Psychopharmacology. ج. 107 ع. 4: 474–9. DOI:10.1007/BF02245258. PMID:1351303. S2CID:6258207.
Rodgers RJ، Cole JC، Davies A (أغسطس 1994). "Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan". Pharmacology, Biochemistry, and Behavior. ج. 48 ع. 4: 959–63. DOI:10.1016/0091-3057(94)90205-4. PMID:7972301. S2CID:39446719.
Grof P، Joffe R، Kennedy S، Persad E، Syrotiuk J، Bradford D (1993). "An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression". International Clinical Psychopharmacology. ج. 8 ع. 3: 167–72. DOI:10.1097/00004850-199300830-00005. PMID:8263314. S2CID:33325915.
Ansseau M، Pitchot W، Moreno AG، Wauthy J، Papart P (2004). "Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature". Human Psychopharmacology: Clinical and Experimental. ج. 8 ع. 4: 279–283. DOI:10.1002/hup.470080407. S2CID:145758823.
Celada P، Bortolozzi A، Artigas F (سبتمبر 2013). "Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research". CNS Drugs. ج. 27 ع. 9: 703–16. DOI:10.1007/s40263-013-0071-0. PMID:23757185. S2CID:31931009.

nih.gov

pubmed.ncbi.nlm.nih.gov

Schoeffter P، Hoyer D (نوفمبر 1988). "Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus". British Journal of Pharmacology. ج. 95 ع. 3: 975–85. DOI:10.1111/j.1476-5381.1988.tb11728.x. PMC:1854240. PMID:3207999.
Pitchot W، Wauthy J، Legros JJ، Ansseau M (مارس 2004). "Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study". European Neuropsychopharmacology. ج. 14 ع. 2: 151–5. DOI:10.1016/S0924-977X(03)00108-1. PMID:15013031. S2CID:19082134.
Hadrava V، Blier P، Dennis T، Ortemann C، de Montigny C (أكتوبر 1995). "Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study". Neuropharmacology. ج. 34 ع. 10: 1311–26. DOI:10.1016/0028-3908(95)00098-Q. PMID:8570029. S2CID:27967032.
Wouters W، Tulp MT، Bevan P (مايو 1988). "Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors". European Journal of Pharmacology. ج. 149 ع. 3: 213–23. DOI:10.1016/0014-2999(88)90651-6. PMID:2842163.
van Hest A، van Drimmelen M، Olivier B (1992). "Flesinoxan shows antidepressant activity in a DRL 72-s screen". Psychopharmacology. ج. 107 ع. 4: 474–9. DOI:10.1007/BF02245258. PMID:1351303. S2CID:6258207.
Rodgers RJ، Cole JC، Davies A (أغسطس 1994). "Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan". Pharmacology, Biochemistry, and Behavior. ج. 48 ع. 4: 959–63. DOI:10.1016/0091-3057(94)90205-4. PMID:7972301. S2CID:39446719.
Grof P، Joffe R، Kennedy S، Persad E، Syrotiuk J، Bradford D (1993). "An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression". International Clinical Psychopharmacology. ج. 8 ع. 3: 167–72. DOI:10.1097/00004850-199300830-00005. PMID:8263314. S2CID:33325915.
Celada P، Bortolozzi A، Artigas F (سبتمبر 2013). "Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research". CNS Drugs. ج. 27 ع. 9: 703–16. DOI:10.1007/s40263-013-0071-0. PMID:23757185. S2CID:31931009.

ncbi.nlm.nih.gov

Schoeffter P، Hoyer D (نوفمبر 1988). "Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus". British Journal of Pharmacology. ج. 95 ع. 3: 975–85. DOI:10.1111/j.1476-5381.1988.tb11728.x. PMC:1854240. PMID:3207999.

semanticscholar.org

api.semanticscholar.org

Pitchot W، Wauthy J، Legros JJ، Ansseau M (مارس 2004). "Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study". European Neuropsychopharmacology. ج. 14 ع. 2: 151–5. DOI:10.1016/S0924-977X(03)00108-1. PMID:15013031. S2CID:19082134.
Hadrava V، Blier P، Dennis T، Ortemann C، de Montigny C (أكتوبر 1995). "Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study". Neuropharmacology. ج. 34 ع. 10: 1311–26. DOI:10.1016/0028-3908(95)00098-Q. PMID:8570029. S2CID:27967032.
van Hest A، van Drimmelen M، Olivier B (1992). "Flesinoxan shows antidepressant activity in a DRL 72-s screen". Psychopharmacology. ج. 107 ع. 4: 474–9. DOI:10.1007/BF02245258. PMID:1351303. S2CID:6258207.
Rodgers RJ، Cole JC، Davies A (أغسطس 1994). "Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan". Pharmacology, Biochemistry, and Behavior. ج. 48 ع. 4: 959–63. DOI:10.1016/0091-3057(94)90205-4. PMID:7972301. S2CID:39446719.
Grof P، Joffe R، Kennedy S، Persad E، Syrotiuk J، Bradford D (1993). "An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression". International Clinical Psychopharmacology. ج. 8 ع. 3: 167–72. DOI:10.1097/00004850-199300830-00005. PMID:8263314. S2CID:33325915.
Ansseau M، Pitchot W، Moreno AG، Wauthy J، Papart P (2004). "Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature". Human Psychopharmacology: Clinical and Experimental. ج. 8 ع. 4: 279–283. DOI:10.1002/hup.470080407. S2CID:145758823.
Celada P، Bortolozzi A، Artigas F (سبتمبر 2013). "Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research". CNS Drugs. ج. 27 ع. 9: 703–16. DOI:10.1007/s40263-013-0071-0. PMID:23757185. S2CID:31931009.